94 related articles for article (PubMed ID: 15580317)
1. [Eptifibatide and percutaneous coronary intervention].
Haude M
Herz; 2004 Nov; 29(7):649-50. PubMed ID: 15580317
[No Abstract] [Full Text] [Related]
2. [Eptifibatide in patients with percutaneous coronary intervention in clinical practice. Results of a prospective registry].
Zeymer U; Zahn R; Siegler KE; Senges J
Herz; 2004 Nov; 29(7):651-5. PubMed ID: 15580318
[TBL] [Abstract][Full Text] [Related]
3. Rapid dissolution of intracoronary thrombus with eptifibatide therapy in a patient with post-infarction angina.
Runyon JP; Snavely DD
J Invasive Cardiol; 2000 Dec; 12 Suppl D():5D-7D. PubMed ID: 11156713
[No Abstract] [Full Text] [Related]
4. Rescue percutaneous coronary intervention using transradial arterial access with glycoprotein IIb/IIIa inhibitor eptifibatide therapy initiated post-fibrinolysis.
Charlat ML
J Invasive Cardiol; 2000 Dec; 12 Suppl D():13D-5D. PubMed ID: 11156716
[No Abstract] [Full Text] [Related]
5. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.
Gibson CM; Morrow DA; Murphy SA; Palabrica TM; Jennings LK; Stone PH; Lui HH; Bulle T; Lakkis N; Kovach R; Cohen DJ; Fish P; McCabe CH; Braunwald E;
J Am Coll Cardiol; 2006 Jun; 47(12):2364-73. PubMed ID: 16781360
[TBL] [Abstract][Full Text] [Related]
6. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial.
Gibson CM; Kirtane AJ; Murphy SA; Rohrbeck S; Menon V; Lins J; Kazziha S; Rokos I; Shammas NW; Palabrica TM; Fish P; McCabe CH; Braunwald E;
Am Heart J; 2006 Oct; 152(4):668-75. PubMed ID: 16996831
[TBL] [Abstract][Full Text] [Related]
7. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II.
Lancet; 1997 May; 349(9063):1422-8. PubMed ID: 9164315
[TBL] [Abstract][Full Text] [Related]
8. Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction.
Raveendran G; Ting HH; Best PJ; Holmes DR; Lennon RJ; Singh M; Bell MR; Long KH; Rihal CS
Mayo Clin Proc; 2007 Feb; 82(2):196-202. PubMed ID: 17290727
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary intervention in a patient with acute non-ST-elevation myocardial infarction and haemophilia A: a 'genous' experience.
Petrillo G; Cirillo P; Leosco D; Maresca F; Piscione F; Chiariello M
Haemophilia; 2011 Jan; 17(1):e245-6. PubMed ID: 20609013
[No Abstract] [Full Text] [Related]
10. Transradial pharmacology: do we need access relevant dosing to maximize outcome?
Gilchrist IC
Catheter Cardiovasc Interv; 2011 Jan; 77(1):69-71. PubMed ID: 20518002
[No Abstract] [Full Text] [Related]
11. Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention.
O'shea JC; Madan M; Cantor WJ; Pacchiana CM; Greenberg S; Joseph DM; Kitt MM; Lorenz TJ; Tcheng JE
Am Heart J; 2000 Dec; 140(6):834-9. PubMed ID: 11099985
[TBL] [Abstract][Full Text] [Related]
12. Prompt use of integrilin (eptifibatide) for unstable angina/subendocardial myocardial infarction: abrupt resolution of chest discomfort marked by brief reperfusion arrhythmias and subsequent stabilization.
Fireman AS
J Invasive Cardiol; 2000 Dec; 12 Suppl D():3D-4D. PubMed ID: 11156712
[No Abstract] [Full Text] [Related]
13. Percutaneous transluminal coronary angioplasty in octogenarians with unstable coronary syndromes.
Rizo-Patron C; Hamad N; Paulus R; Garcia J; Beard E
Am J Cardiol; 1990 Oct; 66(10):857-8. PubMed ID: 2220586
[No Abstract] [Full Text] [Related]
14. [Impact of GP IIb/IIIa antagonists in interventional cardiology].
Scheller B; Hennen B; Böhm M; Nickenig G
Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800
[No Abstract] [Full Text] [Related]
15. Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial.
Marmur JD; Mitre CA; Barnathan E; Cavusoglu E
Am Heart J; 2006 Nov; 152(5):876-81. PubMed ID: 17070148
[TBL] [Abstract][Full Text] [Related]
16. Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial.
Chang WC; Harrington RA; Simoons ML; Califf RM; Lincoff AM; Armstrong PW;
Eur Heart J; 2002 Jul; 23(14):1102-11. PubMed ID: 12090748
[TBL] [Abstract][Full Text] [Related]
17. Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial.
Labinaz M; Kaul P; Harrington RA; Chang WC; Kleiman NS; Simoons ML; Boersma E; Akkerhuis KM; Califf RM; Armstrong PW;
Can J Cardiol; 2004 Jun; 20(8):773-8. PubMed ID: 15229770
[TBL] [Abstract][Full Text] [Related]
18. Delayed profound thrombocytopenia associated with eptifibatide.
Onitilo AA
Am J Hematol; 2006 Dec; 81(12):984. PubMed ID: 16804935
[No Abstract] [Full Text] [Related]
19. Utilization of eptifibatide for treatment of severe dissections as a bail-out procedure.
Latsch A; Suselbeck T; Muth N; Poerner T; Baumbach A; Pfleger S; Borggrefe M; Haase KK
Int J Cardiol; 2004 Aug; 96(2):229-33. PubMed ID: 15262038
[TBL] [Abstract][Full Text] [Related]
20. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia.
Quiles J; Roy D; Gaze D; Garrido IP; Avanzas P; Sinha M; Kaski JC
Am J Cardiol; 2003 Aug; 92(3):322-4. PubMed ID: 12888145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
